An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics
Chemistry – A European Journal · 2026
DOI: 10.1002/chem.71381 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Miaomiao Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Green & Functional Materials and Environmental Chemistry, School of Chemistry and Materials, Yangzhou University…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit nennt 154 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "333 Project" of Jiangsu Province, Yangzhou University.
Abstract (Originalsprache)
Cascade therapies have emerged as a paradigm‐shifting strategy against cancer, exploiting consecutive, self‐amplifying biochemical reactions to convert endogenous or externally supplied substrates into potent cytotoxic species. The marriage of this principle with nanotechnology has birthed “cascade nanotherapeutics”, which has proved augmented anticancer efficacy through integrating temporally coordinated catalytic, photonic, and redox activities within nanoscopic dimensions. In this review, we survey the most recent literature on cascade nanosystems for cancer therapy, proposing an intermediate‐centric view based on the pivotal small‐molecules or physicochemical signals that drive the antitumor cascades. These key intermediates include: (i) H 2 O 2 , (ii) O 2 , (iii) singlet oxygen ( 1 O 2 ), (iv) glutathione (GSH), and (v) localized hyperthermia, (vi) pH, and (vii) NO. For each category, we systematically discuss design principles and mechanistic underpinnings to establish fundamental structure‐activity relationships from a cascading perspective. Finally, we address unresolved challenges and outline future research outlook for next‐generation cascade nanotherapeutics with simple composition, adaptive intelligence, potent efficacy and clinical‐grade biosafety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Provincial Key Laboratory of Green & Functional Materials and Environmental Chemistry, School of Chemistry and Materials, Yangzhou University, Yangzhou, Jiangsu, P. R. China.
ORCID-Profile: Jie Han
Förderung
- National Natural Science Foundation of China
- "333 Project" of Jiangsu Province
- Yangzhou University
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- “333 Project” of Jiangsu Province
Zitieren
APA
Sun, M., Liu, X., Sun, X., & Han, J. (2026). An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics. Chemistry – A European Journal. https://doi.org/10.1002/chem.71381
Vancouver
Sun M, Liu X, Sun X, Han J. An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics. Chemistry – A European Journal. 2026. doi:10.1002/chem.71381
BibTeX
@article{Sun2026,
author = {Sun, Miaomiao and Liu, Xu and Sun, Xiaohuan and Han, Jie},
title = {An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71381}
}
EUVIMED